Studying the Effects of Classic Hallucinogens in the Treatment of Alcoholism: Rationale, Methodology, and Current Research with Psilocybin Read More > March 1, 2013
Role of the 5-HT2A receptor in the locomotor hyperactivity produced by phenylalkylamine hallucinogens in mice Read More > January 29, 2013
Psilocybin Biases Facial Recognition, Goal-Directed Behavior, and Mood State Toward Positive Relative to Negative Emotions Through Different Serotonergic Subreceptors Read More > December 19, 2012
Functional Connectivity Measures After Psilocybin Inform a Novel Hypothesis of Early Psychosis Read More > October 8, 2012
Personality, Psychopathology, Life Attitudes and Neuropsychological Performance among Ritual Users of Ayahuasca: A Longitudinal Study Read More > August 8, 2012
The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions Read More > July 27, 2012
Serotonergic Hallucinogens and Emerging Targets for Addiction Pharmacotherapies Read More > June 1, 2012
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin Read More > January 29, 2012
Drugs as instruments: A new framework for non-addictive psychoactive drug use Read More > November 11, 2011
